TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Intramuscular Drug Delivery Market Research Report 2022

Global Intramuscular Drug Delivery Market Research Report 2022

  • Category:ICT & Media
  • Published on : 22 October 2022
  • Pages :86
  • Formats:
  • Report Code:SMR-7456594
OfferClick for best price

Best Price: $2320

Intramuscular Drug Delivery Market Size, Share 2022


Market Analysis and Insights: Global Intramuscular Drug Delivery Market

The global Intramuscular Drug Delivery market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Intramuscular Drug Delivery market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Intramuscular Drug Delivery market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Intramuscular Drug Delivery market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Intramuscular Drug Delivery market.

Global Intramuscular Drug Delivery Scope and Market Size

Intramuscular Drug Delivery market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Intramuscular Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Drug Molecule

Delivery Devices

Segment by Application

Infectious Disease

Oncology

Autoimmune Diseases

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

By Company

Antares Pharma

Eli Lily

Galaxo

HMD pharmaceuticals

Inovio Pharmaceuticals

Merck

Novartis

Pacira Pharmaceuticals

Pfizer

Pharmajet

Teva Pharmaceutical

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Intramuscular Drug Delivery product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Intramuscular Drug Delivery, with price, sales, revenue, and global market share of Intramuscular Drug Delivery from 2019 to 2022.

Chapter 3, the Intramuscular Drug Delivery competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Intramuscular Drug Delivery breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Intramuscular Drug Delivery market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Intramuscular Drug Delivery.

Chapter 13, 14, and 15, to describe Intramuscular Drug Delivery sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Intramuscular Drug Delivery Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global Intramuscular Drug Delivery Market Research Report 2022
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 86 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Intramuscular Drug Delivery Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Drug Molecule
1.2.3 Delivery Devices
1.3 Market by Application
1.3.1 Global Intramuscular Drug Delivery Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Infectious Disease
1.3.3 Oncology
1.3.4 Autoimmune Diseases
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Intramuscular Drug Delivery Market Perspective (2017-2028)
2.2 Intramuscular Drug Delivery Growth Trends by Region
2.2.1 Intramuscular Drug Delivery Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Intramuscular Drug Delivery Historic Market Size by Region (2017-2022)
2.2.3 Intramuscular Drug Delivery Forecasted Market Size by Region (2023-2028)
2.3 Intramuscular Drug Delivery Market Dynamics
2.3.1 Intramuscular Drug Delivery Industry Trends
2.3.2 Intramuscular Drug Delivery Market Drivers
2.3.3 Intramuscular Drug Delivery Market Challenges
2.3.4 Intramuscular Drug Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Intramuscular Drug Delivery Players by Revenue
3.1.1 Global Top Intramuscular Drug Delivery Players by Revenue (2017-2022)
3.1.2 Global Intramuscular Drug Delivery Revenue Market Share by Players (2017-2022)
3.2 Global Intramuscular Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Intramuscular Drug Delivery Revenue
3.4 Global Intramuscular Drug Delivery Market Concentration Ratio
3.4.1 Global Intramuscular Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Intramuscular Drug Delivery Revenue in 2021
3.5 Intramuscular Drug Delivery Key Players Head office and Area Served
3.6 Key Players Intramuscular Drug Delivery Product Solution and Service
3.7 Date of Enter into Intramuscular Drug Delivery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Intramuscular Drug Delivery Breakdown Data by Type
4.1 Global Intramuscular Drug Delivery Historic Market Size by Type (2017-2022)
4.2 Global Intramuscular Drug Delivery Forecasted Market Size by Type (2023-2028)
5 Intramuscular Drug Delivery Breakdown Data by Application
5.1 Global Intramuscular Drug Delivery Historic Market Size by Application (2017-2022)
5.2 Global Intramuscular Drug Delivery Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Intramuscular Drug Delivery Market Size (2017-2028)
6.2 North America Intramuscular Drug Delivery Market Size by Country (2017-2022)
6.3 North America Intramuscular Drug Delivery Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Intramuscular Drug Delivery Market Size (2017-2028)
7.2 Europe Intramuscular Drug Delivery Market Size by Country (2017-2022)
7.3 Europe Intramuscular Drug Delivery Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Intramuscular Drug Delivery Market Size (2017-2028)
8.2 Asia-Pacific Intramuscular Drug Delivery Market Size by Country (2017-2022)
8.3 Asia-Pacific Intramuscular Drug Delivery Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Intramuscular Drug Delivery Market Size (2017-2028)
9.2 Latin America Intramuscular Drug Delivery Market Size by Country (2017-2022)
9.3 Latin America Intramuscular Drug Delivery Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Intramuscular Drug Delivery Market Size (2017-2028)
10.2 Middle East & Africa Intramuscular Drug Delivery Market Size by Country (2017-2022)
10.3 Middle East & Africa Intramuscular Drug Delivery Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Antares Pharma
11.1.1 Antares Pharma Company Detail
11.1.2 Antares Pharma Business Overview
11.1.3 Antares Pharma Intramuscular Drug Delivery Introduction
11.1.4 Antares Pharma Revenue in Intramuscular Drug Delivery Business (2017-2022)
11.1.5 Antares Pharma Recent Development
11.2 Eli Lily
11.2.1 Eli Lily Company Detail
11.2.2 Eli Lily Business Overview
11.2.3 Eli Lily Intramuscular Drug Delivery Introduction
11.2.4 Eli Lily Revenue in Intramuscular Drug Delivery Business (2017-2022)
11.2.5 Eli Lily Recent Development
11.3 Galaxo
11.3.1 Galaxo Company Detail
11.3.2 Galaxo Business Overview
11.3.3 Galaxo Intramuscular Drug Delivery Introduction
11.3.4 Galaxo Revenue in Intramuscular Drug Delivery Business (2017-2022)
11.3.5 Galaxo Recent Development
11.4 HMD pharmaceuticals
11.4.1 HMD pharmaceuticals Company Detail
11.4.2 HMD pharmaceuticals Business Overview
11.4.3 HMD pharmaceuticals Intramuscular Drug Delivery Introduction
11.4.4 HMD pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2017-2022)
11.4.5 HMD pharmaceuticals Recent Development
11.5 Inovio Pharmaceuticals
11.5.1 Inovio Pharmaceuticals Company Detail
11.5.2 Inovio Pharmaceuticals Business Overview
11.5.3 Inovio Pharmaceuticals Intramuscular Drug Delivery Introduction
11.5.4 Inovio Pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2017-2022)
11.5.5 Inovio Pharmaceuticals Recent Development
11.6 Merck
11.6.1 Merck Company Detail
11.6.2 Merck Business Overview
11.6.3 Merck Intramuscular Drug Delivery Introduction
11.6.4 Merck Revenue in Intramuscular Drug Delivery Business (2017-2022)
11.6.5 Merck Recent Development
11.7 Novartis
11.7.1 Novartis Company Detail
11.7.2 Novartis Business Overview
11.7.3 Novartis Intramuscular Drug Delivery Introduction
11.7.4 Novartis Revenue in Intramuscular Drug Delivery Business (2017-2022)
11.7.5 Novartis Recent Development
11.8 Pacira Pharmaceuticals
11.8.1 Pacira Pharmaceuticals Company Detail
11.8.2 Pacira Pharmaceuticals Business Overview
11.8.3 Pacira Pharmaceuticals Intramuscular Drug Delivery Introduction
11.8.4 Pacira Pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2017-2022)
11.8.5 Pacira Pharmaceuticals Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Detail
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Intramuscular Drug Delivery Introduction
11.9.4 Pfizer Revenue in Intramuscular Drug Delivery Business (2017-2022)
11.9.5 Pfizer Recent Development
11.10 Pharmajet
11.10.1 Pharmajet Company Detail
11.10.2 Pharmajet Business Overview
11.10.3 Pharmajet Intramuscular Drug Delivery Introduction
11.10.4 Pharmajet Revenue in Intramuscular Drug Delivery Business (2017-2022)
11.10.5 Pharmajet Recent Development
11.11 Teva Pharmaceutical
11.11.1 Teva Pharmaceutical Company Detail
11.11.2 Teva Pharmaceutical Business Overview
11.11.3 Teva Pharmaceutical Intramuscular Drug Delivery Introduction
11.11.4 Teva Pharmaceutical Revenue in Intramuscular Drug Delivery Business (2017-2022)
11.11.5 Teva Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Intramuscular Drug Delivery Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Drug Molecule
Table 3. Key Players of Delivery Devices
Table 4. Global Intramuscular Drug Delivery Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Intramuscular Drug Delivery Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Intramuscular Drug Delivery Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Intramuscular Drug Delivery Market Share by Region (2017-2022)
Table 8. Global Intramuscular Drug Delivery Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Intramuscular Drug Delivery Market Share by Region (2023-2028)
Table 10. Intramuscular Drug Delivery Market Trends
Table 11. Intramuscular Drug Delivery Market Drivers
Table 12. Intramuscular Drug Delivery Market Challenges
Table 13. Intramuscular Drug Delivery Market Restraints
Table 14. Global Intramuscular Drug Delivery Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Intramuscular Drug Delivery Market Share by Players (2017-2022)
Table 16. Global Top Intramuscular Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intramuscular Drug Delivery as of 2021)
Table 17. Ranking of Global Top Intramuscular Drug Delivery Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Intramuscular Drug Delivery Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Intramuscular Drug Delivery Product Solution and Service
Table 21. Date of Enter into Intramuscular Drug Delivery Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Intramuscular Drug Delivery Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Intramuscular Drug Delivery Revenue Market Share by Type (2017-2022)
Table 25. Global Intramuscular Drug Delivery Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Intramuscular Drug Delivery Revenue Market Share by Type (2023-2028)
Table 27. Global Intramuscular Drug Delivery Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Intramuscular Drug Delivery Revenue Market Share by Application (2017-2022)
Table 29. Global Intramuscular Drug Delivery Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Intramuscular Drug Delivery Revenue Market Share by Application (2023-2028)
Table 31. North America Intramuscular Drug Delivery Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Intramuscular Drug Delivery Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Intramuscular Drug Delivery Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Intramuscular Drug Delivery Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Intramuscular Drug Delivery Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Intramuscular Drug Delivery Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Intramuscular Drug Delivery Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Intramuscular Drug Delivery Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Intramuscular Drug Delivery Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Intramuscular Drug Delivery Market Size by Country (2023-2028) & (US$ Million)
Table 41. Antares Pharma Company Detail
Table 42. Antares Pharma Business Overview
Table 43. Antares Pharma Intramuscular Drug Delivery Product
Table 44. Antares Pharma Revenue in Intramuscular Drug Delivery Business (2017-2022) & (US$ Million)
Table 45. Antares Pharma Recent Development
Table 46. Eli Lily Company Detail
Table 47. Eli Lily Business Overview
Table 48. Eli Lily Intramuscular Drug Delivery Product
Table 49. Eli Lily Revenue in Intramuscular Drug Delivery Business (2017-2022) & (US$ Million)
Table 50. Eli Lily Recent Development
Table 51. Galaxo Company Detail
Table 52. Galaxo Business Overview
Table 53. Galaxo Intramuscular Drug Delivery Product
Table 54. Galaxo Revenue in Intramuscular Drug Delivery Business (2017-2022) & (US$ Million)
Table 55. Galaxo Recent Development
Table 56. HMD pharmaceuticals Company Detail
Table 57. HMD pharmaceuticals Business Overview
Table 58. HMD pharmaceuticals Intramuscular Drug Delivery Product
Table 59. HMD pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2017-2022) & (US$ Million)
Table 60. HMD pharmaceuticals Recent Development
Table 61. Inovio Pharmaceuticals Company Detail
Table 62. Inovio Pharmaceuticals Business Overview
Table 63. Inovio Pharmaceuticals Intramuscular Drug Delivery Product
Table 64. Inovio Pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2017-2022) & (US$ Million)
Table 65. Inovio Pharmaceuticals Recent Development
Table 66. Merck Company Detail
Table 67. Merck Business Overview
Table 68. Merck Intramuscular Drug Delivery Product
Table 69. Merck Revenue in Intramuscular Drug Delivery Business (2017-2022) & (US$ Million)
Table 70. Merck Recent Development
Table 71. Novartis Company Detail
Table 72. Novartis Business Overview
Table 73. Novartis Intramuscular Drug Delivery Product
Table 74. Novartis Revenue in Intramuscular Drug Delivery Business (2017-2022) & (US$ Million)
Table 75. Novartis Recent Development
Table 76. Pacira Pharmaceuticals Company Detail
Table 77. Pacira Pharmaceuticals Business Overview
Table 78. Pacira Pharmaceuticals Intramuscular Drug Delivery Product
Table 79. Pacira Pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2017-2022) & (US$ Million)
Table 80. Pacira Pharmaceuticals Recent Development
Table 81. Pfizer Company Detail
Table 82. Pfizer Business Overview
Table 83. Pfizer Intramuscular Drug Delivery Product
Table 84. Pfizer Revenue in Intramuscular Drug Delivery Business (2017-2022) & (US$ Million)
Table 85. Pfizer Recent Development
Table 86. Pharmajet Company Detail
Table 87. Pharmajet Business Overview
Table 88. Pharmajet Intramuscular Drug Delivery Product
Table 89. Pharmajet Revenue in Intramuscular Drug Delivery Business (2017-2022) & (US$ Million)
Table 90. Pharmajet Recent Development
Table 91. Teva Pharmaceutical Company Detail
Table 92. Teva Pharmaceutical Business Overview
Table 93. Teva Pharmaceutical Intramuscular Drug DeliveryProduct
Table 94. Teva Pharmaceutical Revenue in Intramuscular Drug Delivery Business (2017-2022) & (US$ Million)
Table 95. Teva Pharmaceutical Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Intramuscular Drug Delivery Market Share by Type: 2021 VS 2028
Figure 2. Drug Molecule Features
Figure 3. Delivery Devices Features
Figure 4. Global Intramuscular Drug Delivery Market Share by Application in 2021 & 2028
Figure 5. Infectious Disease Case Studies
Figure 6. Oncology Case Studies
Figure 7. Autoimmune Diseases Case Studies
Figure 8. Intramuscular Drug Delivery Report Years Considered
Figure 9. Global Intramuscular Drug Delivery Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Intramuscular Drug Delivery Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Intramuscular Drug Delivery Market Share by Region: 2021 VS 2028
Figure 12. Global Intramuscular Drug Delivery Market Share by Players in 2021
Figure 13. Global Top Intramuscular Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intramuscular Drug Delivery as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Intramuscular Drug Delivery Revenue in 2021
Figure 15. North America Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 16. North America Intramuscular Drug Delivery Market Share by Country (2017-2028)
Figure 17. United States Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Canada Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Intramuscular Drug Delivery Market Share by Country (2017-2028)
Figure 21. Germany Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. France Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. U.K. Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Italy Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Russia Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Nordic Countries Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Intramuscular Drug Delivery Market Share by Region (2017-2028)
Figure 29. China Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Japan Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. South Korea Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Southeast Asia Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. India Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Australia Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Intramuscular Drug Delivery Market Share by Country (2017-2028)
Figure 37. Mexico Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Brazil Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Intramuscular Drug Delivery Market Share by Country (2017-2028)
Figure 41. Turkey Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Saudi Arabia Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Antares Pharma Revenue Growth Rate in Intramuscular Drug Delivery Business (2017-2022)
Figure 44. Eli Lily Revenue Growth Rate in Intramuscular Drug Delivery Business (2017-2022)
Figure 45. Galaxo Revenue Growth Rate in Intramuscular Drug Delivery Business (2017-2022)
Figure 46. HMD pharmaceuticals Revenue Growth Rate in Intramuscular Drug Delivery Business (2017-2022)
Figure 47. Inovio Pharmaceuticals Revenue Growth Rate in Intramuscular Drug Delivery Business (2017-2022)
Figure 48. Merck Revenue Growth Rate in Intramuscular Drug Delivery Business (2017-2022)
Figure 49. Novartis Revenue Growth Rate in Intramuscular Drug Delivery Business (2017-2022)
Figure 50. Pacira Pharmaceuticals Revenue Growth Rate in Intramuscular Drug Delivery Business (2017-2022)
Figure 51. Pfizer Revenue Growth Rate in Intramuscular Drug Delivery Business (2017-2022)
Figure 52. Pharmajet Revenue Growth Rate in Intramuscular Drug Delivery Business (2017-2022)
Figure 53. Teva Pharmaceutical Revenue Growth Rate in Intramuscular Drug Delivery Business (2017-2022)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount